TRAF5 and cancer: In addition to the signaling pathways of B cells and T cells revealed by the in vivo studies of TRAF5−/− mice, a number of TRAF5-dependent signaling pathways have been proposed based on the studies of patient samples, cultured human cancer cells or their xenografts in immunodeficient mice.